Mesenchymal stem/stromal cell-based therapies for autism spectrum disorder: emerging evidence and clinical prospects - PubMed
4 hours ago
- #Stem Cell Therapy
- #Clinical Trials
- #Autism Spectrum Disorder
- Mesenchymal stem/stromal cell-based therapies show promise for treating Autism Spectrum Disorder (ASD).
- The article discusses emerging evidence and clinical prospects of these therapies.
- Keywords include Autism spectrum disorder, Cell therapy, Clinical trial, Mesenchymal stem/stromal cell, Regenerative medicine, and Translational medicine.
- No conflicts of interest were declared by the authors.
- References include studies on ASD prevalence, social skills deficits, workplace challenges, and machine learning trends in ASD prediction.